BAJAJ BROKING

Notification close image
No new Notification messages
card image
Scoda Tubes IPO is Open!
Apply for the Scoda Tubes IPO through UPI in just minutes.
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Astonea Labs IPO: Things Smart Investors Need to Know

Astonea Labs Ltd., incorporated in 2017, operates as a contract manufacturer catering to the pharmaceutical and cosmetic sectors, serving both domestic and international clients. The company specialises in a wide range of formulations, including antibiotics, anti-cold medicines, antihistamines, and treatments for conditions such as diabetes, cardiovascular diseases, gynaecological concerns, and infections. Alongside medicinal products, Astonea Labs offers personal care solutions for skin, dental, and hair care—available in formats like creams, gels, serums, oils, ointments, and lotions. These products are developed to meet industry quality standards, reinforcing the company’s focus on safety and compliance.

In addition to contract manufacturing, Astonea Labs markets its own brands—“Glow Up” and “Regero”—in the Indian market, with plans to introduce another brand, “Avicel.” The company also exports to countries such as Iraq and Yemen, while engaging in the trade of packaging and raw materials relevant to its core industries. This diversified operational approach positions Astonea Labs as a noteworthy player in the healthcare and personal care manufacturing space.

For more details, visit the Astonea Labs IPO page.

Astonea Labs IPO Details and Objectives

Details

Information

IPO Date

May 27, 2025 to May 29, 2025

Issue Size

27,90,000 shares

(aggregating up to ₹37.67 Cr)

Price Band

₹128 to ₹135 per share

Lot Size

1000 shares

Listing At

BSE SME

Purpose of the IPO

  • Funding of expenses proposed to be incurred towards registration in Bolivia, South America

  • Purchase and Installation of plants and machineries on the 2nd floor of existing premises of the factory i.e., Haripur, Tehsil – Raipur Rani, District Panchkula, Haryana (“Existing Premises”), for ointment plant as per USFDA guidelines for export purposes

  • Advertising, marketing and brand building

  • Investment in procuring hardware and software

  • Funding for working Capital requirements

  • General corporate purposes

Timeline of Astonea Labs Papers IPO

Event

Date

IPO Open Date

Tue, May 27, 2025

IPO Close Date

Thu, May 29, 2025

Tentative Allotment

Fri, May 30, 2025

Initiation of Refunds

Mon, Jun 2, 2025

Credit of Shares to Demat

Mon, Jun 2, 2025

Tentative Listing Date

Tue, Jun 3, 2025

Cut-off time for UPI mandate confirmation

5 PM on May 29, 2025

Pricing & Lot Size of Astonea Labs IPO

Price Band for the IPO

  • ₹128 to ₹135 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Retail (Min)

1

1000

₹1,35,000

Retail (Max)

1

1000

₹1,35,000

HNI (Min)

2

2,000

₹2,70,000

How to Apply for the Astonea Labs IPO?

Online Application Process

  • Log in to Your Trading Account
    Access your trading account through your broker’s platform.

  • Navigate to the IPO Section
    Go to the IPO section to view active IPO listings.

  • Select Astonea Labs IPO
    Find "Astonea Labs IPO" and click on the ‘Apply’ button.

  • Enter Application Details
    Specify the number of lots (minimum lot size: 1000 shares) and the bid price within the range of ₹128 to ₹135 per share.

  • Provide Your UPI ID
    Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.

  • Review and Submit
    Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on May 29, 2025, to complete your application process.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹52.91 crore in FY22 to ₹96.52 crore as of December 2024.

  • Revenue: Reached ₹69.69 crore in FY24.

  • Profit After Tax (PAT): Stood at ₹4.10 crore for December 2024.

  • Net Worth: Increased from ₹7.49 crore in FY22 to ₹17.28 crore as of December 2024.

  • Reserves and Surplus: Recorded at ₹9.56 crore (Dec 2024), growing steadily over the years.

  • Total Borrowings: Stood at ₹49.48 crore in December 2024.

Recent Performance and Growth Prospects

  • The company has shown a steady rise in its asset base, reflecting ongoing business expansion and operational scaling.

  • Revenue generation has progressed consistently, indicating strong market demand and effective sales execution.

  • Profitability has improved over time, highlighting better cost management and operational efficiency.

  • The company's net worth has strengthened, suggesting improved financial stability and shareholder value creation.

  • Reserves and surplus have seen healthy growth, pointing to reinvestment capability and retained earnings.

  • While borrowings have increased, it suggests the business is leveraging capital to support its growth and expansion initiatives.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company’s presence in international markets such as Iraq and Yemen may expose it to geopolitical and regulatory uncertainties, potentially affecting export operations.

  • Increased borrowings and upcoming capital expenditure for expansion and compliance could place short-term pressure on liquidity and financial flexibility.

Opportunities and Growth Potential

  • Astonea Labs Ltd established manufacturing base, experienced leadership, and consistent expansions offer strong potential for scaling operations in the growing packaging and specialty paper segments.

  • The IPO funding aims to boost capacity through a power plant and meet working capital needs, enabling operational efficiency and positioning the company for long-term sustainable growth.

Key Performance Indicator (KPI)

KPI

Values

ROE

37.86%

ROCE

22.95%

Debt/Equity

2.16

RoNW

31.83%

PAT Margin

4.75

Price to Book Value

8.57

Astonea Labs IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

Kfin Technologies Limited 

Oneview Corporate Advisors Pvt. Ltd. 

Company Address of Astonea Labs Ltd

Astonea Labs Ltd

House No. 1358,

1st Floor,

Sector-22B,

Phone: +91 9888302323

Email: cs@astonea.org

Website: https://www.astonea.org/

Conclusion

Astonea Labs Ltd. operates across pharmaceutical and personal care segments through contract manufacturing and its own product brands. Its business activities span domestic and international markets, with an emphasis on compliance, product variety, and expansion of manufacturing capacity. The company’s involvement in packaging and raw material trade adds to its operational scope.

The IPO proceeds are intended to support activities including plant installation, brand marketing, working capital, and regulatory registrations. These steps align with the company's objective to scale operations in both local and export markets.

Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Astonea Labs IPO.

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|